Council Members in this Study Group: 280
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Sunil Dhawan, MDClinical Assistant Professor of Dermatology
STANFORD UNIVERSITY ![]()
Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trialdivision...
Dermatologist
Brian W Lester, MD ![]()
Brian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety of agents used in psoriasis (e.g. retinoids and...
Michele Pauporte, MDDermatologist
JUVA SKIN LASER CENTER INC ![]()
Michele Pauporte, MD, is a dermatologist at Juva Skin and Laser Center, in New York City. Dr. Pauporte's areas of expertise include cosmetic procedures and the treatment of skin cancers, including Mohs micrographic surgery and reconstructive surgery. She is also extremely experienced in the use oflasers,...
Plastic and Reconstructive Physician
Michael A Bain, MD ![]()
Michael Bain, MD, MS, is a Plastic and Reconstructive Physician in private practice based in Southern California. He has experience in all areas of plastic and reconstructive surgery including bariatric, breast, cosmetic, and reconstructive surgery. Dr. Bain’s interests are in the ever changing nature...
Owner
ROBERT KOPPEL ![]()
Robert Koppel, MD, is a Dermatologist in private practice in Metairie, Louisiana. He also serves as an Assistant Clinical Professor of Dermatology at the Tulane University School of Medicine. Dr. Koppel is knowledgeable of all aspects of medical, surgical, and cosmetic dermatology, with a particular...
Clinical Instructor
MOUNT SINAI SCHOOL OF MEDICINE OF ![]()
Kenneth Edelson, MD, FAACS, is a Clinical Instructor at Mount Sinai School of Medicine and attending at The Mount Sinai Hospital. He is an NYC Dermatologist in practice for over 25 years and specializes in cosmetic dermatologic surgery and skin cancer. Dr. Edelson uses lasers and IPL's for facial rejuvenation,...
Mark Jewell, MDPlastic Surgeon
MARK L JEWELL MD PC ![]()
Mark Jewell, MD, is a Plastic Surgeon in private practice in Eugene, Oregon. Dr. Jewell is the past President of the American Society for Aesthetic Plastic Surgery (ASAPS), a select group of board-certified plastic surgeons who have attained the highest level of achievement in cosmetic surgical training,...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Presta Trial shows good results for Enbrel
October 14, 2009
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY
New data from PRESTA trial demonstrate the benefit of Enbrel in patients with psoriasis & psoriatic arthritis | www.pharmabiz.com
This trial showed predicatably good results for Enbrel in patients with psoriasis and psoriatic arthritis. This included improvement in signs and symptoms and quality of life. This will increase sales of Enbrel in the short term. However the two newer agents, Humira and Stelara have better efficacy,...
July 26, 2009
Peplin Initiates its Final Phase 3 Clinical Trial for PEP005 Gel in AK | www.pipelinereview.com
New product that only requires 2 application days over an area. May be useful. Typical source for a product like this, coming from a plant extract. Considering that 5-flourouracil has several variations, but all have predictable reactions that need minimally a few weeks to heal, it is worth looking...
Will the withdrawl of Efalizumab effect the biologic market?
April 15, 2009
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY
Efalizumab withdrawn from US Market | www.medscape.com
This article is important in that the withdrawal of efalizumab by Genentech was appropriate in view of its serious side effect of progressive multifocal leukoencephalopathy (PML). This biologic agent was already declining in usage because of its other side effects, and the presence of other strongcompetitors...
March 11, 2009
Multivitamins: Fact or Fiction | www.usatoday.com
As I ask patients, what is the antioxidant measure we have for the body to show antioxidants work?
Aurobindo terbinafine approval- what effect will this have?
January 21, 2009
Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY
Aurobindo Pharma gets approval for Terbinafine Tablets | myiris.com
This article is important in that it confirms another terbinafine competitor to the Novartis Lamisil brand is being released. The majority of terbinafine prescriptions in North America are generic. The market for this product will be good at least until more effective oral or topical agents are released....
| Study Group Name | No. Members |
|---|---|
| Hair Restoration Dermatologists (US) | 285 |
| Dermatologists (US) | 620 |
| Cosmetic Dermatologists | 349 |
| Cosmetic Dermatologists in Private Practice (US) | 182 |
| Physicians who Treat Acne (US) | 303 |
| Users of Dermal Fillers (US) | 139 |
| Physicians who Treat Rosacea (US) | 135 |